Drug Profile

KW 3635

Latest Information Update: 26 May 2001

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Kyowa Hakko
Class Antiplatelets; Benzimidazoles; Benzoxepins; Small molecules; Thrombolytics
Mechanism of Action Thromboxane A2 receptor antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

26 May 2001 Discontinued-I for Ischaemic heart disorders in Japan (Unknown route)
26 May 2001 Discontinued-I for Thrombosis in Japan (Unknown route)
06 Nov 1997 No-Development-Reported for Ischaemic heart disorders in Japan (Unknown route)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com